Literature DB >> 19688613

The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome.

Hyejin Lee1, Jee-Young Oh, Yeon-Ah Sung, Hyewon Chung, Wha Young Cho.   

Abstract

Insulin resistance and hyperinsulinemia play important roles in the pathogenesis of polycystic ovary syndrome (PCOS). In addition, some women with PCOS have been shown to have insulin secretory defects and can be predicted to be at an increased risk for glucose intolerance. We performed the present study to determine the prevalence and risk factors for glucose intolerance in Korean women with PCOS. We consecutively recruited 194 women with PCOS diagnosed by American Society for Reproductive Medicine/European Society of Human Reproduction and Embryology (ASRM/ESHRE) criteria. Anthropometric measures, 75 g oral glucose tolerance test (OGTT), and measurement of insulin sensitivity (insulin mediated glucose uptake; IMGU) using euglycemic hyperinsulinemic clamp technique were performed. In women with PCOS, the prevalence of impaired glucose tolerance (IGT) and/or impaired fasting glucose (IFG) was 17.0% and type 2 diabetes 1.0%, and in lean women with PCOS, the prevalence of IGT and/or IFG was 5.9%. The prevalence of glucose intolerance was 28-fold higher in women with PCOS, and 9.8-fold higher in lean women with PCOS compared to age-matched Korean women. Women with glucose intolerance had higher BMI, waist circumference, free testosterone, fasting insulin, 2-h post-load insulin, total cholesterol, LDL cholesterol, triglyceride and lower sex hormone binding globulin and IMGU than women with normal glucose tolerance (NGT) (P < 0.05). IMGU was the most powerful predictor for glucose intolerance after adjustment for age, BMI, waist circumference, and hyperandrogenemia. The 2-h OGTT was the best screening measure for glucose intolerance and diagnosis of diabetes in women with PCOS. Young Korean women with PCOS have high prevalence for glucose intolerance and type 2 diabetes, and insulin resistance is the most important factor associated with glucose intolerance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19688613     DOI: 10.1007/s12020-009-9226-7

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  28 in total

1.  Standards of medical care in diabetes--2007.

Authors: 
Journal:  Diabetes Care       Date:  2007-01       Impact factor: 19.112

2.  Comparative study on evaluation methods for serum testosterone level for PADAM diagnosis.

Authors:  A Tsujimura; K Matsumiya; Y Miyagawa; T Takao; K Fujita; S Takada; M Koga; A Iwasa; M Takeyama; A Okuyama
Journal:  Int J Impot Res       Date:  2005 May-Jun       Impact factor: 2.896

3.  Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin.

Authors:  D Cibula; G Sindelka; M Hill; M Fanta; J Skrha; J Zivny
Journal:  Hum Reprod       Date:  2002-01       Impact factor: 6.918

4.  Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome.

Authors:  Xiaoli Chen; Dongzi Yang; Lin Li; Shuying Feng; Liangan Wang
Journal:  Hum Reprod       Date:  2006-05-09       Impact factor: 6.918

Review 5.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

Authors:  A Dunaif
Journal:  Endocr Rev       Date:  1997-12       Impact factor: 19.871

6.  Insulin resistance in nonobese patients with polycystic ovary syndrome.

Authors:  S Toprak; A Yönem; B Cakir; S Güler; O Azal ; M Ozata; A Corakçi
Journal:  Horm Res       Date:  2001

7.  Predictors of abnormal glucose metabolism in women with polycystic ovary syndrome.

Authors:  Matthias Möhlig; Joachim Spranger; Michael Ristow; Andreas F H Pfeiffer; Thilo Schill; Hans W Schlösser; Lothar Moltz; Georg Brabant; Christof Schöfl
Journal:  Eur J Endocrinol       Date:  2006-02       Impact factor: 6.664

8.  Prevalence and factor analysis of metabolic syndrome in an urban Korean population.

Authors:  Jee-Young Oh; Young Sun Hong; Yeon-Ah Sung; Elizabeth Barrett-Connor
Journal:  Diabetes Care       Date:  2004-08       Impact factor: 19.112

9.  Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.

Authors:  R S Legro; A R Kunselman; W C Dodson; A Dunaif
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

10.  Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.

Authors:  S Lillioja; D M Mott; M Spraul; R Ferraro; J E Foley; E Ravussin; W C Knowler; P H Bennett; C Bogardus
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

View more
  14 in total

1.  Metabolic abnormalities in adolescents with polycystic ovary syndrome in south China.

Authors:  Jia Huang; Renmin Ni; Xiaoli Chen; Lili Huang; Yaqin Mo; Dongzi Yang
Journal:  Reprod Biol Endocrinol       Date:  2010-11-17       Impact factor: 5.211

Review 2.  Glucose intolerance states in women with the polycystic ovary syndrome.

Authors:  R Pasquali; A Gambineri
Journal:  J Endocrinol Invest       Date:  2013-09       Impact factor: 4.256

3.  The Usefulness of Homeostatic Measurement Assessment-Insulin Resistance (HOMA-IR) for Detection of Glucose Intolerance in Thai Women of Reproductive Age with Polycystic Ovary Syndrome.

Authors:  Thanyarat Wongwananuruk; Manee Rattanachaiyanont; Pichai Leerasiri; Suchada Indhavivadhana; Kitirat Techatraisak; Surasak Angsuwathana; Prasong Tanmahasamut; Chongdee Dangrat
Journal:  Int J Endocrinol       Date:  2012-04-24       Impact factor: 3.257

4.  How does acupuncture affect insulin sensitivity in women with polycystic ovary syndrome and insulin resistance? Study protocol of a prospective pilot study.

Authors:  Yanhua Zheng; Elisabet Stener-Victorin; Ernest H Y Ng; Juan Li; Xiaoke Wu; Hongxia Ma
Journal:  BMJ Open       Date:  2015-05-03       Impact factor: 2.692

Review 5.  Clinical characteristics in Taiwanese women with polycystic ovary syndrome.

Authors:  Ming-I Hsu
Journal:  Clin Exp Reprod Med       Date:  2015-09-30

6.  Prevalence and clinical profile of insulin resistance in young women of poly cystic ovary syndrome: A study from Pakistan.

Authors:  Rumina Tabassum; Fouzia Imtiaz; Shaheen Sharafat; Shazia Shukar-Ud-Din; Uzma Nusrat
Journal:  Pak J Med Sci       Date:  2013-04       Impact factor: 1.088

7.  Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome.

Authors:  Do Kyeong Song; Hyejin Lee; Yeon Ah Sung; Jee Young Oh
Journal:  Yonsei Med J       Date:  2016-11       Impact factor: 2.759

Review 8.  Dyslipidemia in women with polycystic ovary syndrome.

Authors:  Jin Ju Kim; Young Min Choi
Journal:  Obstet Gynecol Sci       Date:  2013-05-16

9.  Association of obesity and overweight with the prevalence of insulin resistance, pre-diabetes and clinical-biochemical characteristics among infertile Mexican women with polycystic ovary syndrome: a cross-sectional study.

Authors:  Enrique Reyes-Muñoz; Carlos Ortega-González; Nayeli Martínez-Cruz; Lidia Arce-Sánchez; Guadalupe Estrada-Gutierrez; Carlos Moran; Ana Paola Sánchez-Serrano; Rodolfo Higareda-Sánchez; Julio Francisco de la Jara-Díaz
Journal:  BMJ Open       Date:  2016-07-22       Impact factor: 2.692

Review 10.  Pathophysiology, risk factors, and screening methods for prediabetes in women with polycystic ovary syndrome.

Authors:  Evgenia Gourgari; Elias Spanakis; Adrian Sandra Dobs
Journal:  Int J Womens Health       Date:  2016-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.